Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Rufinamide

An antiepileptic approved in Europe in 2007 and in the United States in 2008 as add-on therapy for seizures in Lennox-Gastaut syndrome, a rare and severe form of epilepsy that begins in childhood. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It is a triazole derivative carrying two fluorine atoms: it binds to sodium channels in nerve cells and keeps them from switching to their active state, damping down abnormal electrical discharges.

RufinamideGo to the active ingredient →
RufinamideActive ingredientRufinamideCat. No. P-R096-001CAS 106308-44-5

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.